Figure 5.
Figure 5. Sox6–/– erythroid cells have decreased survival and proliferation rates in vitro. (A) AnnV/7-AAD FACS profiles of control and Sox6–/– erythroid cells cultured on fibronectin with 0.2 U/mL Epo for 12 and 48 hours. The quadrants in each plot correspond to live cells (AnnV–/7-AAD–), apoptotic cells (AnnV+/7-AAD–), dead cells (AnnV+/7-AAD+), and necrotic cells (AnnV–/7-AAD+). (B) Graphs showing the percentages of apoptotic (AnnV+/7-AAD–) proerythroblasts and erythroblasts in cell cultures on fibronectin for 12 hours with the indicated concentrations of Epo. (C) BrdU incorporation assay in control and Sox6–/– erythroid cells cultured on fibronectin with 0.2 U/mL Epo for 12 hours and 48 hours. The percentages of BrdU+ cells are indicated. (D) Graphs showing the percentages of BrdU+ proerythroblasts and erythroblasts in cell cultures on fibronectin for 12 hours with the indicated concentrations of Epo.

Sox6–/– erythroid cells have decreased survival and proliferation rates in vitro. (A) AnnV/7-AAD FACS profiles of control and Sox6–/– erythroid cells cultured on fibronectin with 0.2 U/mL Epo for 12 and 48 hours. The quadrants in each plot correspond to live cells (AnnV/7-AAD), apoptotic cells (AnnV+/7-AAD), dead cells (AnnV+/7-AAD+), and necrotic cells (AnnV/7-AAD+). (B) Graphs showing the percentages of apoptotic (AnnV+/7-AAD) proerythroblasts and erythroblasts in cell cultures on fibronectin for 12 hours with the indicated concentrations of Epo. (C) BrdU incorporation assay in control and Sox6–/– erythroid cells cultured on fibronectin with 0.2 U/mL Epo for 12 hours and 48 hours. The percentages of BrdU+ cells are indicated. (D) Graphs showing the percentages of BrdU+ proerythroblasts and erythroblasts in cell cultures on fibronectin for 12 hours with the indicated concentrations of Epo.

Close Modal

or Create an Account

Close Modal
Close Modal